this post was submitted on 18 Nov 2025
151 points (99.3% liked)
science
22582 readers
43 users here now
A community to post scientific articles, news, and civil discussion.
rule #1: be kind
founded 2 years ago
MODERATORS
you are viewing a single comment's thread
view the rest of the comments
view the rest of the comments
$26,500/yr for a drug that doesn't actually help a person with dementia.
How many times is the FDA going to approve beta amyloid lowering drugs that have no benefit to disease? isn't lowering beta amyoid and not affecting disease just proof, in humans, that the beta amyloid hypothesis is wrong?
Drugs like Lecanemab don't help in that they don't reverse the progression of symptoms, but they do help in that they slow down the progression of symptoms. You'd expect someone who was given the drug for a few months to have more of their cognative ability left than someone who hadn't had it, but they'd both be much worse than they were at the start.
Yeah, and I'm not sure that a drug that reverses the symptoms is a realistic target anyway. As far as I'm aware, Alzheimer's ultimately kills neurons. They ain't coming back without a time machine. A treatment that stops degeneration is as good a goal as we're gonna get.
Like, if I lose a limb in a car accident, is it really fair to say that the intervention required to let me live on as an amputee didn't work, since it couldn't grow my limb back?